Results 151 to 160 of about 1,999,370 (297)
Molecular Oncology, EarlyView.Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
Molecular Oncology, EarlyView.LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
[Texas Instruments Press Releases, April-June 1968]
, 1968 1. Press release dated April 1, 1968 from the GSI subsidiary of TI announces the development of a Digital-Air Gun Seismic System for shallow and deep-water exploration. An image of a man holding the device, with a caption, is included. 2.
Texas Instruments Incorporated
core
Molecular Oncology, EarlyView.Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source
[Texas Instruments Press Releases, April-June 1962]
, 1962 1. Release dated April 2, 1962 announces the establishment of the position of Senior Scientist and appointed three members of the technical staff to these positions: Dr. Dmetro Andrychuk, Dr. Morton E. Jones and Dr. King Walters. Brief biographies of the
Texas Instruments Incorporated
core
Molecular Oncology, EarlyView.This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi +6 more
wiley +1 more source
[Texas Instruments Press Releases, September-December 1968]
, 1968 1. Memo dated September 16, 1968 from Bob Florsheim to ''Communicators'' at TI and is in regard to an archive of 1968 press releases. 2. Press release dated October 8, 1968 announces the award of the 1969 Industrial Research Institute Medal to TI ...
Texas Instruments Incorporated
core
Molecular Oncology, EarlyView.Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani +9 more
wiley +1 more source
[Texas Instruments Press Releases, September-December 1964]
, 1964 1. Release dated September 1, 1964 is in regard to the radar subsystem which TI developed for the F-111A aircraft. An image with drawings to indicate the system's capabilities is included. 2.
Texas Instruments Incorporated
core
A comparative evaluation of the resistance to vertical root fracture after removal of separated instruments using three instrument retrieval systems: An <i>in vitro</i> study. [PDF]
J Conserv Dent EndodLobo WMV +4 more
europepmc +1 more source